Physician profile
Julie Voss
NPI 1356309678
$1,017.55
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $509 · 2020: $154 · 2021: $136 · 2022: $88.22 · 2023: $58.32 · 2024: $72.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $131.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $514.72 | 2019-2024 | |
| Leo Pharma INC. | $98.23 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $94.19 | 2019-2024 | |
| Lilly USA, LLC | $79.57 | 2019-2020 | |
| Pfizer INC. | $59.07 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $41.31 | 2020-2021 | |
| Genzyme Corporation | $31.14 | 2019-2023 | |
| Abbvie INC. | $23.23 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $22.93 | 2019 | |
| Dermira, INC. | $19.02 | 2019 | |
| Mayne Pharma Commercial LLC | $17.25 | 2020 | |
| Celgene Corporation | $16.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Voss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.